Navigation Links
AtheroGenics Reports ARISE Trial Results for AGI-1067

rk may take a significant period of time to complete or require significant additional resources to complete, or that AstraZeneca could terminate its collaboration agreement with us based on the results of the clinical trial. We cannot ensure that AGI-1067 will ever be approved or be proven safe and effective for use in humans. These and other risks are discussed in AtheroGenics' Securities and Exchange Commission filings, including, but not limited to, the risks discussed in AtheroGenics' Annual Report on Form 10-K for the fiscal year ended December 31, 2006. The risk factors regarding AtheroGenics that are included under the caption "Risk Factors" in AtheroGenics' Annual Report on Form 10-K for the fiscal year ended December 31, 2006 are specifically incorporated by reference into this press release. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


AtheroGenics, Inc.

Mark P. Colonnese

Chief Financial Officer

678-336-2511

Email Contact


Media Inquiries

Jayme Maniatis

Schwartz Communications, Inc.

781-684-0770 ext. 6610

Email Contact


Investor Inquiries

Lilian Stern

Stern Investor Relations, Inc.

212-362-1200

Email Contact

'"/>




Page: 1 2 3 4

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: AtheroGenics Reports ARISE Trial Results for AGI
(Date:12/14/2009)... Seven leading cancer physicians ... Oncology Research participated in studies ... 2009 San Antonio Breast Cancer ... the Henry B. Gonzalez Convention ... . Fifteen others presented their ...
(Date:12/14/2009)... BEACH, Fla., Dec. 14 Perry Baromedical, ... years, announces the launch of the Sigma Elite, ... technology of the Sigma Elite is available on ... ) and has a Patent Pending. ,, The ... Data Capture Via Computerized System for Each ...
(Date:12/14/2009)... Diagnostics, Inc. is pleased to announce that the ... patent number 7,599,057 titled "Method and Apparatus for ... the company. The patent covers the core technology ... issuance of this patent supports the underlying strategy ... and commercialization," said Dave Dingott, CEO and President ...
Breaking Medicine Technology:US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 2US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 3US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 4US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 5US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 6US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 7US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 8US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 9Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability 2Chinese Devil Dung Plant Could Be a Swine Flu Fighter 56608 1Some Parents Arent Giving Kids Pain Meds Post Surgery 56606 1Some Parents Arent Giving Kids Pain Meds Post Surgery 56606 2Some Parents Arent Giving Kids Pain Meds Post Surgery 56606 3Vespa Pink Campaign Supports Fight Against Breast Cancer 56604 1Vespa Pink Campaign Supports Fight Against Breast Cancer 56604 2Vespa Pink Campaign Supports Fight Against Breast Cancer 56604 3Vespa Pink Campaign Supports Fight Against Breast Cancer 56604 4Vespa Pink Campaign Supports Fight Against Breast Cancer 56604 5
(Date:12/15/2009)... -- Connectyx Technologies Holding Group Inc. (Pink Sheets: ... a higher listing level on the Pink Sheets ... positions Connectyx as a Transparent Company with Adequate ... President Ronn Schuman stated, "We are excited to ... to become a fully reporting company. This ...
(Date:12/15/2009)... clean transition to new coding system. , ... ... -- The American Academy of Professional Coders ( AAPC ) ... for health plans across the country beginning January. Developed specifically ... and reimbursement experts, the on-site trainings are designed to enable ...
(Date:12/15/2009)... your trust as the most caring, conscientious practice you have ever ... the Dermatology Center of Dallas, we can help to achieve this ... ... (PRWEB) December 15, 2009 -- The Dermatology Center of Dallas, a ... arrival of Jeri Beth “J.B.” Foshee, MD in their practice. ...
(Date:12/15/2009)... Marketstrat is pleased to announce the release of a new ... addresses world markets for clinical devices used to treat and ... ... CA (PRWEB) December 15, 2009 -- Marketstrat is pleased to ... Markets Worldwide.” The report specifically addresses world markets for ...
(Date:12/14/2009)... Young Adults, Attitudes and Behavior Regarding Pregnancy, Contraception, and ... -- Nearly all unmarried young adults ages 18-29 believe ... men and 86% of women) and say that it ... now (86% of men and 88% of women), according ... Prevent Teen and Unplanned Pregnancy. Even so: ,, ...
Breaking Medicine News(10 mins):Health News:Connectyx Attains 'Current Listing' Status on Pink Sheets Exchange 2Health News:Connectyx Attains 'Current Listing' Status on Pink Sheets Exchange 3Health News:AAPC Now Offers On-site ICD-10 Training for Health Plans Nationwide 2Health News:AAPC Now Offers On-site ICD-10 Training for Health Plans Nationwide 3Health News:Jeri Beth “J.B.” Foshee, MD Joins Dermatology Center of Dallas 2Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 2Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 3Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3
... mumps beginning in Nova Scotia and now spreading in Ontario. ... affected. ,The latest outbreak of five people in ... has put health officials in top alert. ,Public-health ... booster shot, as the latest attacks prove that those vaccinated ...
... own wife or sons keep surfacing with monotonous regularity, especially from ... a South Carolina man held his wife and two sons captive ... since been sent to jail. ,The man identified as ... only that room was found tidy when the police raided ...
... more likely than men to develop osteoporosis, or porous bone, ... which can lead to debilitating - or even life-threatening - ... causes of osteoporosis are numerous, but in women, low estrogen ... ,As for men - new research at Washington University ...
... and the consequent quarantine of a woman has cost the ... cough up $75,000 dollars now. ,Based on ... case manager who had worked with high-risk obstetrics patients, isolated ... of February, said Deputy County Attorney Lori Alesio and Ryan's ...
... been unaffected by the rapidly increasing price of gas, which ... some parts of the United States . And consumers arent ... University professor has found. ,Research conducted by Wayne ... documents that Americans work attitudes have been affected as the ...
... ,"We call them dates," she said of the men with whom she ... dark hair off her slight shoulders and out of her smoky eyes. ... her large hands and Adam's apple seem obvious. But at first -- ... wasn't a girl her entire life. ,She prostitutes herself "about ...
Other Medicine News:Health News:Mumps Breaks Out In Canada 2Health News:Man Keeps Wife and Sons in Maggot-infested House 2Health News:Estrogen is Important for Bone Health in Men as Well as Women 2Health News:US County to Compensate Woman Wrongly Quarantined for TB 2Health News:Higher Gas Prices Leave Many Workers Running on Empty 2Health News:Making Change: The Cost of Being Transgender 2Health News:Making Change: The Cost of Being Transgender 3Health News:Making Change: The Cost of Being Transgender 4Health News:Making Change: The Cost of Being Transgender 5
Polyester ribbon impregnated with conjugated Protein A - .25 OD per sq. cm....
Polyester ribbon impregnated with conjugated Protein G - .25 OD per sq. cm....
Colloidal Gold Sol, 40 nm - 12 - 15, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Onyx Liquid Embolic System is a device utilized for the pre-surgical embolization of arteriovenous malformations (AVMs)....
Medicine Products: